vs
Side-by-side financial comparison of Confluent, Inc. (CFLT) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Confluent, Inc. is the larger business by last-quarter revenue ($314.8M vs $185.2M, roughly 1.7× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -25.2%, a 26.1% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 20.5%). Confluent, Inc. produced more free cash flow last quarter ($41.7M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 20.4%).
Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CFLT vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $314.8M | $185.2M |
| Net Profit | $-79.2M | $1.7M |
| Gross Margin | 74.7% | 85.7% |
| Operating Margin | -31.5% | 8.6% |
| Net Margin | -25.2% | 0.9% |
| Revenue YoY | 20.5% | 23.7% |
| Net Profit YoY | 10.0% | -88.5% |
| EPS (diluted) | $-0.23 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $314.8M | $185.2M | ||
| Q3 25 | $298.5M | $169.1M | ||
| Q2 25 | $282.3M | $154.7M | ||
| Q1 25 | $271.1M | $125.2M | ||
| Q4 24 | $261.2M | $149.7M | ||
| Q3 24 | $250.2M | $141.5M | ||
| Q2 24 | $235.0M | $126.7M | ||
| Q1 24 | $217.2M | $110.4M |
| Q4 25 | $-79.2M | $1.7M | ||
| Q3 25 | $-66.5M | $17.3M | ||
| Q2 25 | $-82.0M | $-24.4M | ||
| Q1 25 | $-67.6M | $-21.7M | ||
| Q4 24 | $-88.1M | $14.7M | ||
| Q3 24 | $-74.1M | $-6.7M | ||
| Q2 24 | $-89.9M | $-15.7M | ||
| Q1 24 | $-93.0M | $-48.4M |
| Q4 25 | 74.7% | 85.7% | ||
| Q3 25 | 74.2% | 88.5% | ||
| Q2 25 | 73.7% | 90.2% | ||
| Q1 25 | 74.5% | 90.7% | ||
| Q4 24 | 74.1% | 90.1% | ||
| Q3 24 | 74.5% | 90.6% | ||
| Q2 24 | 72.3% | 91.1% | ||
| Q1 24 | 71.8% | 87.7% |
| Q4 25 | -31.5% | 8.6% | ||
| Q3 25 | -27.9% | 20.3% | ||
| Q2 25 | -34.2% | -6.1% | ||
| Q1 25 | -37.3% | -6.3% | ||
| Q4 24 | -40.5% | 10.7% | ||
| Q3 24 | -37.4% | 15.3% | ||
| Q2 24 | -46.1% | 11.8% | ||
| Q1 24 | -51.3% | -25.1% |
| Q4 25 | -25.2% | 0.9% | ||
| Q3 25 | -22.3% | 10.2% | ||
| Q2 25 | -29.0% | -15.8% | ||
| Q1 25 | -24.9% | -17.3% | ||
| Q4 24 | -33.7% | 9.8% | ||
| Q3 24 | -29.6% | -4.8% | ||
| Q2 24 | -38.3% | -12.4% | ||
| Q1 24 | -42.8% | -43.9% |
| Q4 25 | $-0.23 | $0.00 | ||
| Q3 25 | $-0.19 | $0.06 | ||
| Q2 25 | $-0.24 | $-0.08 | ||
| Q1 25 | $-0.20 | $-0.07 | ||
| Q4 24 | $-0.26 | $0.05 | ||
| Q3 24 | $-0.23 | $-0.02 | ||
| Q2 24 | $-0.28 | $-0.05 | ||
| Q1 24 | $-0.30 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $347.2M | $293.5M |
| Total DebtLower is stronger | $1.1B | $392.7M |
| Stockholders' EquityBook value | $1.2B | $274.2M |
| Total Assets | $3.0B | $949.9M |
| Debt / EquityLower = less leverage | 0.94× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $347.2M | $293.5M | ||
| Q3 25 | $298.5M | $263.8M | ||
| Q2 25 | $295.6M | $231.0M | ||
| Q1 25 | $278.6M | $250.6M | ||
| Q4 24 | $386.0M | $249.9M | ||
| Q3 24 | $322.6M | $249.8M | ||
| Q2 24 | $311.3M | $260.1M | ||
| Q1 24 | $336.4M | $239.6M |
| Q4 25 | $1.1B | $392.7M | ||
| Q3 25 | $1.1B | $392.0M | ||
| Q2 25 | $1.1B | $391.3M | ||
| Q1 25 | $1.1B | $390.7M | ||
| Q4 24 | $1.1B | $390.1M | ||
| Q3 24 | $1.1B | $389.5M | ||
| Q2 24 | $1.1B | $388.9M | ||
| Q1 24 | $1.1B | $388.4M |
| Q4 25 | $1.2B | $274.2M | ||
| Q3 25 | $1.1B | $230.4M | ||
| Q2 25 | $1.1B | $204.3M | ||
| Q1 25 | $1.0B | $193.6M | ||
| Q4 24 | $961.2M | $194.0M | ||
| Q3 24 | $934.3M | $178.8M | ||
| Q2 24 | $873.9M | $132.5M | ||
| Q1 24 | $845.2M | $130.7M |
| Q4 25 | $3.0B | $949.9M | ||
| Q3 25 | $2.9B | $868.8M | ||
| Q2 25 | $2.8B | $815.3M | ||
| Q1 25 | $2.7B | $789.8M | ||
| Q4 24 | $2.7B | $785.0M | ||
| Q3 24 | $2.6B | $786.6M | ||
| Q2 24 | $2.5B | $749.5M | ||
| Q1 24 | $2.4B | $721.8M |
| Q4 25 | 0.94× | 1.43× | ||
| Q3 25 | 0.98× | 1.70× | ||
| Q2 25 | 1.03× | 1.92× | ||
| Q1 25 | 1.07× | 2.02× | ||
| Q4 24 | 1.14× | 2.01× | ||
| Q3 24 | 1.17× | 2.18× | ||
| Q2 24 | 1.25× | 2.93× | ||
| Q1 24 | 1.29× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | $16.3M |
| Free Cash FlowOCF − Capex | $41.7M | $16.0M |
| FCF MarginFCF / Revenue | 13.2% | 8.6% |
| Capex IntensityCapex / Revenue | 0.1% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $60.7M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.1M | $16.3M | ||
| Q3 25 | $30.8M | $35.7M | ||
| Q2 25 | $18.1M | $-26.5M | ||
| Q1 25 | $-26.8M | $7.8M | ||
| Q4 24 | $35.2M | $-3.9M | ||
| Q3 24 | $15.6M | $-23.0M | ||
| Q2 24 | $8.6M | $22.7M | ||
| Q1 24 | $-26.0M | $-29.7M |
| Q4 25 | $41.7M | $16.0M | ||
| Q3 25 | $30.0M | $35.3M | ||
| Q2 25 | $17.2M | $-28.9M | ||
| Q1 25 | $-28.2M | $7.5M | ||
| Q4 24 | $34.5M | $-4.2M | ||
| Q3 24 | $15.0M | $-23.3M | ||
| Q2 24 | $7.5M | $21.6M | ||
| Q1 24 | $-26.1M | $-31.5M |
| Q4 25 | 13.2% | 8.6% | ||
| Q3 25 | 10.0% | 20.9% | ||
| Q2 25 | 6.1% | -18.7% | ||
| Q1 25 | -10.4% | 6.0% | ||
| Q4 24 | 13.2% | -2.8% | ||
| Q3 24 | 6.0% | -16.5% | ||
| Q2 24 | 3.2% | 17.0% | ||
| Q1 24 | -12.0% | -28.5% |
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 0.3% | 0.2% | ||
| Q2 25 | 0.3% | 1.6% | ||
| Q1 25 | 0.5% | 0.2% | ||
| Q4 24 | 0.3% | 0.2% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.5% | 0.9% | ||
| Q1 24 | 0.1% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFLT
| Confluent Cloud | $169.4M | 54% |
| Post Contract Customer Support | $93.8M | 30% |
| License | $38.4M | 12% |
| Services | $13.2M | 4% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |